Pro-ObamaCare group launches ad ahead of vote on HHS nominee

Pro-ObamaCare group launches ad ahead of vote on HHS nominee
© Getty Images

A pro-ObamaCare group has launched a digital ad ahead of the Senate Finance Committee’s vote on President TrumpDonald John TrumpBrennan fires new shot at Trump: ‘He’s drunk on power’ Trump aides discussed using security clearance revocations to distract from negative stories: report Trump tried to dissuade Melania from 'Be Best' anti-bullying campaign: report MORE’s nominee to lead the department charged with implementing the health law.

The ad running online Wednesday in Washington, D.C., points out what ObamaCare supporters view as the White House’s attempts to sabotage the law in list form. Various items on the list are checked off, such as “rip away health care from millions of Americans (3.2 million and counting…),” “slash open enrollment in half,”  “undermine essential health benefits” and more.

ADVERTISEMENT

The ad is a nod to a document Sen. Bob CaseyRobert (Bob) Patrick CaseyTop Koch official fires back at critics: We are not an 'appendage' of the GOP Dem senator: Media should stop covering Trump rallies like they're breaking news The Hill's Morning Report: Trump tries to rescue Ohio House seat as GOP midterm fears grow MORE Jr. (D-Pa.) released last week from the Department of Health and Human Services (HHS) that detailed ways the department has examined changing ObamaCare through administrative action. Former HHS Secretary Tom PriceThomas (Tom) Edmunds PricePelosi seizes on anti-corruption message against GOP White House staff offered discounts at Trump's NJ golf club: report GOP lawmaker calls for ethics rules changes after Collins charged with insider trading MORE handed out the document in a March 23 meeting with the conservative House Freedom Caucus as the chamber was working to repeal ObamaCare.

“The Trump HHS has been secretly sabotaging the American health care system from the very beginning, and now 3 million Americans have lost their coverage,” Protect Our Care Campaign Director Brad Woodhouse said in a release. “Now that they’ve been caught red-handed, the Trump Administration and its HHS nominee must promise to end these attacks on our care.”

The ad comes as the Senate Finance Committee votes Wednesday to send the nomination of Alex Azar to serve as the head of HHS to the Senate floor.

His confirmation before the full Senate is likely, as only one GOP senator — Sen. Rand PaulRandal (Rand) Howard PaulHillicon Valley: Trump escalates feud with intel critics | Tesla shares fall after troubling Musk interview | House panel considers subpoena for Twitter's Jack Dorsey | Why Turkish citizens are breaking their iPhones Overnight Defense: Trump cancels military parade, blames DC for cost | DC mayor hits back | Pentagon warns China 'likely' training for strikes against US | Turkey refuses to release US pastor On Russia we need diplomacy, not just sanctions MORE (R-Ky.) — has expressed concerns and at least two Democrats — Sens. Heidi HeitkampMary (Heidi) Kathryn HeitkampThe Hill's Morning Report: Dems have a majority in the Senate (this week) Overnight Health Care: Supreme Court nomination reignites abortion fight in states | Trump urges Sessions to sue opioid makers | FDA approves first generic version of EpiPen Judge rules against Trump attempt to delay Obama water rule MORE (N.D.) and Joe ManchinJoseph (Joe) ManchinOvernight Health Care: Senate takes up massive HHS spending bill next week | Companies see no sign of drugmakers cutting prices, despite Trump claims | Manchin hits opponent on ObamaCare lawsuit Manchin hits opponent on ObamaCare lawsuit with new ad The Hill's Morning Report: Dems have a majority in the Senate (this week) MORE (W.Va.) — have already said they would vote to confirm him.

Azar spent nearly 10 years as a pharmaceutical executive at Eli Lilly, most recently serving as Lilly USA’s president — a post he left in January 2017.

He previously served at HHS, first as general counsel from 2001 to 2005 and then as deputy secretary for two years. His former colleagues say he’s fluent in the regulatory process, which could come in handy as the Trump administration looks to change ObamaCare on its own. It seems unlikely GOP lawmakers will take another stab at repealing the health law.